Tag: discordance
Articles
- Hormone receptor and HER2 status changes can influence prognosis
- Latest research concerning HER2 positive breast cancer prognosis
- Latest research concerning triple negative breast cancer prognosis
- Tumor characteristics influencing prognosis of triple negative breast cancer
News
- Estrogen receptor status tends to remain stable during progression to metastasis
- Hormone receptor status changes during progression in over one-third of breast cancer cases
- Knowing the receptor status of metastases improves treatment decisions
- Survival times for metastatic breast cancer have been improving
Studies
- Changes in estrogen receptor, progesterone receptor and her-2/neu status with time: discordance rates between primary and metastatic breast cancer
- Clinically Used Breast Cancer Markers Are Heterogeneous Throughout Tumour Progression
- Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease
- Concordance in histological and biological parameters between first and second primary breast cancers
- Discordance in hormone receptor status in breast cancer during tumor progression
- Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study
- HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
- Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients
- Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer
- Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
- Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor
- Prognostic Value of a Positive-to-negative Change in Hormone Receptor Status after Neoadjuvant Chemotherapy in Patients with Hormone Receptor-positive Breast Cancer
- Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
- Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
- Stability of estrogen receptor status in breast carcinoma
- Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
- Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma